“I believed in the power of PhysioPD when I first saw it twenty-five years ago, I’ve had a passion for it ever since, and now we have enough experience that I know it works.”
—Ron Beaver, PhD, Founder

About Rosa & Co

Rosa was founded in 2002 and remains an employee-owned, science-focused, and client-friendly firm. Today, Rosa is the worldwide commercial leader in PhysioPD-style Research, with comprehensive basic biology and therapeutic experience, industry-leading modeling expertise, and repeat research engagements with a majority of the Top 20 pharmaceutical companies.

Rosa's ForecastMD Platforms, which offers a credible methodology for determining expected physician uptake for healthcare products, was started by Bill Brastow, Ph.D., in 2005. Our models have helped shape first-in-class markets including novel therapy combinations for HIV and molecular diagnostic tests for Oncology.

Rosa’s staff bring more than a century of aggregate experience in applying modeling to the inherent challenges faced by drug developers and have authored hundreds of scientific posters, conference presentations, relevant patents, and peer-reviewed publications.

Recent Highlights

Rosa Co-authors on ISoP Outstanding Research Manuscript Award Article

The International Society of Pharmacometrics has announced the Outstanding Research Manuscript Award for 2023 is “Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clini... Read More

Rosa presentations at ACoP14

Rosa will present a talk and a poster at the Fourteenth American Conference on Pharmacometrics (ACoP14). Dr. Friedrich will present “QSP Modelers – Take Your Data Seriously, Not Literally!” during the Roller Coaster 2 session on Wednesday, 11/8/23. D... Read More

Rosa to attend HEOR Summit

Rosa’s Brian Schneider will attend the Health Economics & Outcomes Research (HEOR) Summit December 12 - 14, 2023 in Philadelphia, PA. https://heor-summit.com/... Read More

The Rosa & Co. Executive Team